Ultragenyx Pharmaceutical (RARE) FCF Margin (QoQ) (2016 - 2026)
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) FCF Margin (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.56 Bn | 1.27 Bn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,979.00 |
| Mar 31, 2026 | -9,697.00 |
| Dec 31, 2025 | 906.00 |
| Sep 30, 2025 | 940.00 |
| Jun 30, 2025 | 5,308.00 |
| Mar 31, 2025 | -6,701.00 |
| Dec 31, 2024 | -394.00 |
| Sep 30, 2024 | 453.00 |
| Jun 30, 2024 | 12,448.00 |
| Mar 31, 2024 | -11,100.00 |
| Dec 31, 2023 | 5,679.00 |
| Sep 30, 2023 | -387.00 |
| Jun 30, 2023 | 6,088.00 |
| Mar 31, 2023 | -6,749.00 |
| Dec 31, 2022 | 2,032.00 |
| Sep 30, 2022 | -1,275.00 |
| Jun 30, 2022 | 6,620.00 |
| Mar 31, 2022 | -10,287.00 |
| Dec 31, 2021 | 1,382.00 |
| Sep 30, 2021 | -2.00 |